Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs

被引:99
作者
Bourne, N
Bravo, FJ
Francotte, M
Bernstein, DI
Myers, MG
Slaoui, M
Stanberry, LR
机构
[1] Childrens Hosp, Med Ctr, Div Infect Dis, Cincinnati, OH USA
[2] GlaxoSmithKline Biol, Rixensart, Belgium
关键词
D O I
10.1086/374002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In two recent clinical trials, a vaccine containing herpes simplex virus (HSV) type 2 glycoprotein D (gD2) and a novel adjuvant AS04 comprising alum (Al) and 3-deactylated monophosphoryl lipid A (3-dMPL) afforded HSV-seronegative women significant protection against HSV-2 genital disease (vaccine efficacy, 73% in study 1 and 74% in study 2) and limited protection against infection (46% in study 1 and 39% in study 2). In the present report, studies in the guinea pig model investigated the protection afforded by gD2/AS04 against HSV-1 and HSV-2 genital herpes and investigated whether immunization could prevent or reduce recurrent disease in guinea pigs that developed mucosal infection. Immunization with gD2/AS04 conveyed nearly complete protection against primary disease with either virus but did not prevent mucosal infection. Guinea pigs immunized with gD2/AS04 were significantly better protected against recurrent disease than were guinea pigs immunized with a gD2/Al vaccine, which suggests that inclusion of 3-dMPL improved protection against latent infection.
引用
收藏
页码:542 / 549
页数:8
相关论文
共 41 条
  • [41] Herpes simplex virus infections
    Whitley, RJ
    Roizman, B
    [J]. LANCET, 2001, 357 (9267) : 1513 - 1518